Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR8YU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,667
Award facts
- Contract value 100% obligated
- $43,666.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $43,666.99 by the Defense Logistics Agency on January 14, 2026, for the supply of Kesimpta 20 mg/0.4 ml pen auto-injectors. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through full and open competition. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of January 15, 2026. This delivery order is executed under AmerisourceBergen's parent company Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 single-award vehicle valued through December 31, 2031, which serves as the primary mechanism for delivering comprehensive pharmaceutical and medical supply support to military healthcare programs globally.
Kesimpta (ofatumumab) is a monoclonal antibody immunosuppressant used in the treatment of multiple sclerosis, reflecting the Defense Logistics Agency's ongoing procurement of specialized therapeutic medications to support the Defense Health Agency and other military healthcare systems. The delivery order exemplifies AmerisourceBergen's established role as a critical pharmaceutical distributor within the federal supply chain, capable of efficiently fulfilling government requirements for brand-name specialty medications across multiple therapeutic domains. The contractor's extensive portfolio of federal awards and significant prime vendor status underscores its proven capability to meet military healthcare procurement standards.
Quick answers
Who was awarded contract SPE2DR26FR8YU?
SPE2DR26FR8YU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FR8YU worth?
The government has obligated $43,667 on SPE2DR26FR8YU.
Is contract SPE2DR26FR8YU an order under another contract?
Yes. SPE2DR26FR8YU is a delivery order under SPE2DR25D3018, an indefinite delivery contract.
Was contract SPE2DR26FR8YU competed?
The extent of competition for SPE2DR26FR8YU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award